Strasser, S;
              
      
            
                Abou-Alfa, G;
              
      
            
                Mollon, P;
              
      
            
                Meyer, T;
              
      
            
                Cheng, A;
              
      
            
                El-Khoueiry, A;
              
      
            
                Kelley, R;
              
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
            ... Freemantle, N; + view all
            
          
      
        
        
        
    
  
(2019)
  Quality-adjusted life-years accrued with cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial.
    Presented at: Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “The Universe Within”, Adelaide, Australia.
  
  
  
       
    
  
| Preview | Text Freemantle_Quality-adjusted life-years accrued with cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial_AAM.pdf - Accepted Version Download (253kB) | Preview | 
Archive Staff Only
|  | View Item | 
 
                      
